Mylan may have violated antitrust law in its EpiPen sales to schools

For years, Mylan Pharmaceuticals has been selling the devices to schools at a discounted price, giving them a break from rising costs. But the program also prohibited schools from buying competitors’ devices — a provision that experts say may have violated antitrust law.

Continue reading the article here.

If you would like to submit content or write an article for the Health Care & Life Sciences page, please email Kim Ferguson at kferguson@indybar.org.